Symbol="BCRX"
AssetType="Common Stock"
Name="BioCryst Pharmaceuticals Inc"
Description="BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina."
CIK="882796"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1348996000"
EBITDA="-111277000"
PERatio="None"
PEGRatio="-0.28"
BookValue="-2.051"
DividendPerShare="0"
DividendYield="0"
EPS="-1.25"
RevenuePerShareTTM="1.634"
ProfitMargin="-0.791"
OperatingMarginTTM="-0.368"
ReturnOnAssetsTTM="-0.136"
ReturnOnEquityTTM="-19.25"
RevenueTTM="306641000"
GrossProfitTTM="10936000"
DilutedEPSTTM="-1.25"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.259"
AnalystTargetPrice="15.1"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="8.45"
PriceToBookRatio="56.59"
EVToRevenue="9.45"
EVToEBITDA="-23.51"
Beta="1.893"
num_52WeekHigh="15.12"
num_52WeekLow="6.62"
num_50DayMovingAverage="7.46"
num_200DayMovingAverage="9.35"
SharesOutstanding="188935000"
DividendDate="None"
ExDividendDate="None"
symbol="BCRX"
open="6.90"
high="7.18"
low="6.79"
price="7.14"
volume="1490735.00"
latest_trading_day="2023-08-14"
previous_close="6.97"
change="0.17"
change_percent="2.4390%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="84"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="16"
Volume_recent_avg="2692428"
Change_recent_avg="-0.03"
Delta_recent_avg="0.32"
Variance_recent_avg="0.16"
Change_ratio_recent_avg="-0.44"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="16"
Aroon_momentum_negative="84"
image_negative_thumbnail_id_1="111"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0065.jpeg"
image_negative_thumbnail_id_2="143"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0033.jpeg"
image_neutral_thumbnail_id_1="535"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0064.jpeg"
image_neutral_thumbnail_id_2="591"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_positive_thumbnail_id_1="653"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0055.jpeg"
image_positive_thumbnail_id_2="615"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0093.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
